Perioperative management of patients treated with angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers: A quality improvement audit

Anaesthesia and Intensive Care

Volumn 44, Issue 3, 2016, Pages 346-352

  Vijay, A ^a   Grover, A ^b   Coulson, T G ^b   Myles, P S ^b  

^a ALFRED HOSPITAL   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

ACE inhibitors; Acute kidney injury; Acute renal failure; Angiotensin II receptor blockers; Angiotensin converting enzyme inhibitors; ARBs; Atrial fibrillation; Hypotension; Intraoperative; Perioperative

Indexed keywords

ANESTHETIC AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; EPHEDRINE; INFUSION FLUID; METARAMINOL;

ACUTE KIDNEY FAILURE; ARTICLE; ATRIAL FIBRILLATION; CEREBROVASCULAR ACCIDENT; CORONARY ARTERY DISEASE; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DRUG USE; DRUG WITHDRAWAL; ELECTIVE SURGERY; FEMALE; HEART FAILURE; HEART INFARCTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; OBSERVATIONAL STUDY; PERIOPERATIVE PERIOD; RECOVERY ROOM; TRANSIENT ISCHEMIC ATTACK; URINE VOLUME; VASCULAR DISEASE; VITAL SIGN; ACUTE KIDNEY INJURY; AGED; HYPOTENSION; INCIDENCE; METHODOLOGY; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROCEDURES; PROSPECTIVE STUDY; STATISTICAL BIAS;

ACUTE KIDNEY INJURY; AGED; ANGIOTENSIN RECEPTOR ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ATRIAL FIBRILLATION; BIAS (EPIDEMIOLOGY); CONFOUNDING FACTORS (EPIDEMIOLOGY); FEMALE; HUMANS; HYPOTENSION; INCIDENCE; MALE; MIDDLE AGED; PERIOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; RESEARCH DESIGN;

EID: 84977762622     PISSN: 0310057X     EISSN: 14480271     Source Type: Journal    
DOI: 10.1177/0310057x1604400305     Document Type: Article

References (56)

1. Australian Bureau of Statistics. Australian Health Survey: Health Service Usage and Health Related Actions, 2011-12. From: http://www.abs.gov.au/ausstats/abs@nsf/Lookup/6B9ADBD21549598ECA257B39000F3117. Accessed April 2013.
2. Weiser TG, Regenbogen SE. Thompson KD et al. An estimation of the global volume of surgery: a modelling strategy based on available data. Lancet 2008; 372:139-144.
3. Chul Y Y, Young-Nam Y. Kwang SJ et al. Effects of reninangiotensin system inhibitors on the occurrence of acute kidney injury following off-pump coronary artery bypass grafting. Circ J 2010; 74:1852-1858.
4. Mehran S, Zohreh Y. Noori AF et al. The effect of angiotensinconverting enzyme inhibitor on hemodynamic instability in patients undergoing cardiopulmonary bypass: results of a dose comparison study. J Cardiovasc Pharmacol Ther 2009; 14:185-191.
5. Kheterpal S, Khodaparast O. Shanks A et al. Chronic angiotensin converting enzyme inhibitor or angiotensin receptor blocker therapy combined with diuretic therapy is associated with increased episodes of hypotension in noncardiac surgery. J Cardiothorac Vasc Anesth 2008; 22:180-186.
6. Oh YJ, Lee JH. Nam SB et al. Effects of chronic angiotensin II receptor antagonist and angiotensin-converting enzyme inhibitor treatments on neurohormonal levels and haemodynamics during cardiopulmonary bypass. Br J Anaesth 2006; 97:792-798.
7. Graciane R, Carlos BL. Vieira da Costa GJC et al. The use of inhibitors of angiotensin-converting enzyme and its relation to events in the postoperative period of CABG. Rev Bras Cir Cardiovasc 2011; 26:373-379.
8. Miceli A, Capoun R. Fino C et al. Effects of angiotensin converting enzyme inhibitor therapy on clinical outcome in patients undergoing coronary artery bypass grafting. J Am Coll Cardiol 2009; 54:1778-1784.
9. Licker M, Schweizer A, Hohn L, Morel DR. Chronic angiotensin converting inhibition does not influence renal hemodynamic and function during cardiac surgery. Can J Anaesth 1999; 46:626-634.
10. Deakin CD, Dalrymple-Hay MJ, Jones P, Monro JL. Effects of angiotensin converting enzyme inhibition on systemic vascular resistance and vasoconstrictor requirements during hypothermic cardiopulmonary bypass. Eur J Cardiothorac Surg 1998; 13:546-550.
11. Tuman KJ, McCarthy RJ. O'Connor CJ et al. Angiotensin converting enzyme inhibitors increase vasoconstrictor requirements after cardiopulmonary bypass. Anesth Analg 1995; 80:473-479.
12. Rosenman DJ, McDonald FS. Ebbert JO et al. Clinical consequences of withholding versus administering reninangiotensin-aldosterone system antagonists in the preoperative period. J Hosp Med 2008; 3:319-325.
13. Lee YK, Na SW, Kwak YL, Nam SB. Effect of pre-operative angiotensin-converting enzyme inhibitors on haemodynamic parameters and vasoconstrictor requirements in patients undergoing off-pump coronary artery bypass surgery. J Int Med Res 2005; 33:693-702.
14. Ryckwaert F, Colson P. Hemodynamic effects of anesthesia in patients with ischemic heart failure chronically treated with angiotensin-converting enzyme inhibitors. Anesth Analg 1997; 84:945-949.
15. Schulte E, Ziegler D. Philippi-Hohne C et al. Angiotensinconverting enzyme inhibition and blood pressure response during total intravenous anaesthesia for minor surgery. Acta Anaesthesiol Scand 2011; 55:435-443.
16. Auron M, Harte B, Kumar A, Michota F. Renin-angiotensin system antagonists in the perioperative setting: clinical consequences and recommendations for practice. Postgrad Med J 2011; 87:472-481.
17. Arora P, Kolli H, Nainani N, Nader N, Lohr J. Preventable risk factors for acute kidney injury in patients undergoing cardiac surgery. J Cardiothorac Vasc Anesth 2012; 26:687-697.
18. Chertow GM, Levy EM. Hammermeister KE et al. Independent association between acute renal failure and mortality following cardiac surgery. Am J Med 1998; 104:343-348.
19. Kincaid EH, Ashburn DA. Hoyle J et al. Does the combination of aprotinin and angiotensin-converting enzyme inhibitor cause renal failure after cardiac surgery? Ann Thorac Surg 2005; 80:1388-1393.
20. Doddakula K, Al-Sarraf N. Gately K et al. Predictors of acute renal failure requiring renal replacement therapy post cardiac surgery in patients with preoperatively normal renal function. Interact Cardiovasc Thorac Surg 2007; 6:314-318.
21. Antonio JL, Paulo FF. Sofia J et al. Acute kidney injury in intensive care unit patients: a comparison between the RIFLE and the Acute Kidney Injury Network classifications. Crit Care 2008; 12:R110.
22. Ilknur B, Ahmet A. Ali OM et al. Acute renal failure following open heart surgery: risk factors and prognosis. Perfusion 2005; 20:317-322.
23. Regner KR, Connolly HM, Schaff HV, Albright RC. Acute renal failure after cardiac surgery for carcinoid heart disease: incidence, risk factors, and prognosis. Am J Kidney Dis 2005; 45:826-832.
24. Salman JB, Waleed TK. Vei-Vei L et al. Outcomes of preoperative angiotensin-converting enzyme inhibitor therapy in patients undergoing isolated coronary artery bypass grafting. Am J Cardiol 2012; 110:919-923.
25. Arora P, Rajagopalam S. Ranjan R et al. Preoperative use of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers is associated with increased risk for acute kidney injury after cardiovascular surgery. Clin J Am Soc Nephrol 2008; 3:1266-1273.
26. Railton CJ, Wolpin J, Lam-McCulloch J, Belo SE. Reninangiotensin blockade is associated with increased mortality after vascular surgery. Can J Anaesth 2010; 57:736-744.
27. Shah M, Jain AK. Brunelli SM et al. Association between angiotensin converting enzyme inhibitor or angiotensin receptor blocker use prior to major elective surgery and the risk of acute dialysis. BMC Nephrol 2014; 15:53.
28. Johnston K, Stephens S. Effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on risk of atrial fibrillation before coronary artery bypass grafting. Ann Pharmacother 2012; 46:1239-1244.
29. Baker WL, White CM. Post-cardiothoracic surgery atrial fibrillation: a review of preventive strategies. Ann Pharmacother 2007; 41:587-598.
30. David HL, Peter KS. Jeffrey AL et al. 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: executive summary: a report of the American College of Cardiology Foundation/ American Heart Association Task Force on Practice Guidelines. Circulation 2011; 124:2610-2642.
31. Rafal D, Cezary S, Agnieszka J, Grzegorz R, Ilona K, Hanna S. ACE inhibitor therapy: Possible effective prevention of newonset atrial fibrillation following cardiac surgery. Cardiol J 2007; 14:274-280.
32. Philip M P. Introduction: American College of Chest Physicians guidelines for the prevention and management of postoperative atrial fibrillation after cardiac surgery. Chest 2005; 128:6S-8S.
33. Mathew J P, Parks R. Savino JS et al. Atrial fibrillation following coronary artery bypass graft surgery: predictors, outcomes, and resource utilization. MultiCenter study of perioperative ischemia research group. JAMA 1996; 276:300-306.
34. Almassi GH, Schowalter T. Nicolosi AC et al. Atrial fibrillation after cardiac surgery: a major morbid event? Ann Surg 1997; 226:501-513.
35. Aranki SF, Shaw D P. Adams DH et al. Predictors of atrial fibrillation after coronary artery surgery. Current trends and impact on hospital resources. Circulation 1996; 94:390-397.
36. Mathew J P, Fontes ML. Tudor IC et al. A multicenter risk index for atrial fibrillation after cardiac surgery. JAMA 2004; 291:1720-1729.
37. Roop K, Hernandez AV, Masood I, Gillinov AM, Saliba W, Blackstone EH. Short- and long-term mortality associated with new-onset atrial fibrillation after coronary artery bypass grafting: a systematic review and meta-analysis. J Thorac Cardiovasc Surg 2011; 141:1305-1312.
38. Nasir S, Steven Z, Sherrine E, Michael JW, Muneeruddin MQ. Demographic determinants and effect of pre-operative angiotensin converting enzyme inhibitors and angiotensin receptor blockers on the occurrence of atrial fibrillation after CABG surgery. BMC Cardiovasc Disord 2010; 10:7.
39. Ozaydin M, Dede O. Varol E et al. Effect of renin-angiotensin aldosteron system blockers on postoperative atrial fibrillation. Int J Cardiol 2008; 127:362-367.
40. Viachaslau B, Scott S. Ning Z et al. Preoperative reninangiotensin system inhibitors protect renal function in aging patients undergoing cardiac surgery. J Surg Res 2011; 167:e63-69.
41. White CM, Kluger J, Lertsburapa K, Faheem O, Coleman CI. Effect of preoperative angiotensin converting enzyme inhibitor or angiotensin receptor blocker use on the frequency of atrial fibrillation after cardiac surgery: a cohort study from the atrial fibrillation suppression trials II and III. Eur J Cardiothorac Surg 2007; 31:817-820.
42. Magee MJ, Herbert MA. Dewey TM et al. Atrial fibrillation after coronary artery bypass grafting surgery: development of a predictive risk algorithm. Ann Thorac Surg 2007; 83:1707-1712.
43. Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, Levin A. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007; 11:R31.
44. Devitt JH, Rapanos T, Kurrek M, Cohen MM, Shaw M. The anesthetic record: accuracy and completeness. Can J Anaesth 1999; 46:122-128.
45. Lerou JG, Dirksen R, van Daele M, Nijhuis GM, Crul JF. Automated charting of physiological variables in anesthesia: a quantitative comparison of automated versus handwritten anesthesia records. J Clin Monit 1988; 4:37-47.
46. Byrne AJ, Jones JG. Inaccurate reporting of simulated critical anaesthetic incidents. Br J Anaesth 1997; 78:637-641.
47. Byrne AJ, Sellen AJ, Jones JG. Errors on anaesthetic record charts as a measure of anaesthetic performance during simulated critical incidents. Br J Anaesth 1998; 80:58-62.
48. Cook RI, McDonald JS, Nunziata E. Differences between handwritten and automatic blood pressure records. Anesthesiology 1989; 71:385-390.
49. Coriat P, Richer C. Douraki T et al. Influence of chronic angiotensin-converting enzyme inhibition on anesthetic induction. Anesthesiology 1994; 81:299-307.
50. Bertrand M, Godet G, Meersschaert K, Brun L, Salcedo E, Coriat P. Should the angiotensin II antagonists be discontinued before surgery? Anesth Analg 2001; 92:26-30.
51. Kheterpal S, Khodaparast O, Shanks A, O'Reilly M, Tremper KK. Chronic angiotensin-converting enzyme inhibitor or angiotensin receptor blocker therapy combined with diuretic therapy is associated with increased episodes of hypotension in noncardiac surgery. J Cardiothorac Vasc Anesth 2008; 22:180-186.
52. Comfere T, Sprung J. Kumar MM et al. Angiotensin system inhibitors in a general surgical population. Anesth Analg 2005; 100:636-644.
53. Calvert S, Shaw A. Perioperative acute kidney injury. Perioper Med (Lond) 2012; 1:6.
54. Borthwick E, Ferguson A. Perioperative acute kidney injury: risk factors, recognition, management, and outcomes. BMJ 2010; 341:c3365.
55. Cittanova ML, Zubicki A. Savu C et al. The chronic inhibition of angiotensin-converting enzyme impairs postoperative renal function. Anesth Analg 2001; 93:1111-1115.
56. Ho KM, Lewis J P. Prevention of atrial fibrillation in cardiac surgery: time to consider a multimodality pharmacological approach. Cardiovasc Ther 2010; 28:59-65.